Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination Formulations
Open Access
- 30 September 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (9), e7270
- https://doi.org/10.1371/journal.pone.0007270
Abstract
Malaria continues to be one of the major public health problems in Africa, Asia and Latin America. Artemisinin derivatives (ARTs; artesunate, artemether, and dihydroartemisinin) derived from the herb, Artemisia annua, are the most effective antimalarial drugs available providing rapid cures. The World Health Organisation (WHO) has recommended that all antimalarials must be combined with an artemisinin component (artemisinin-based combination therapy; ACT) for use as first line treatment against malaria. This class of drugs is now first-line policy in most malaria-endemic countries. Reports of ad hoc surveys from South East Asia show that up to 50% of the artesunate currently sold is counterfeit. Drug quality is rarely assessed in resource poor countries in part due to lack of dedicated laboratory facilities which are expensive to build, equip and maintain. With a view to address this unmet need we developed two novel colour reaction assays that can be used in the field to check the quality of ARTs. Our assays utilise thin layer chromatography silica gel sheets and 2, 4 dinitrophenylhydrazine or 4-Benzoylamino-2, 5-dimethoxybenzenediazonium chloride hemi (zinc chloride) salt as the reagents showing a pink or blue product respectively only in the presence ARTs. We are able to detect as low as 10% of ARTs in ACTs (WINTHROP - artesunate/amodiaquine, Coartem®-artemether/lumefantrine and Duocortexcin - dihydroartemisinin/piperaquine). The assays have been validated extensively by testing eighty readily accessible and widely used drugs in malaria endemic countries. None of the other antimalarial drugs or a range of commonly used excipients, antiretroviral drugs or other frequently used drugs from the WHO essential drugs list such as analgesics or antibiotics are detected with our assays. Our two independent assays requiring no specialist training are specific, simple to use, rapid, robust, reproducible, inexpensive and, have successfully resulted in detecting two counterfeit drugs within a small scale screening survey of over 100 declared artemisinin-containing drugs collected from various Asian and African countries. These promising results indicate that the assays will provide a useful first test to assure the quality of the ACTs formulations in resource poor malaria endemic areas when there is an absence of dedicated medicines quality laboratory facilities.Keywords
This publication has 17 references indexed in Scilit:
- A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in TanzaniaPLOS ONE, 2008
- Malaria research, 1980–2004, and the burden of diseaseActa Tropica, 2008
- Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country StudyPLOS ONE, 2008
- Artesunate and Dihydroartemisinin (DHA): Unusual Decomposition Products Formed under Mild Conditions and Comments on the Fitness of DHA as an Antimalarial DrugChemMedChem, 2007
- Quality control of active ingredients in artemisinin‐derivative antimalarials within Kenya and DR CongoTropical Medicine & International Health, 2006
- Counterfeit and substandard antimalarial drugs in CambodiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Manslaughter by Fake Artesunate in Asia—Will Africa Be Next?PLoS Medicine, 2006
- Murder by medicineNature, 2005
- Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Application of precolumn reaction to high-performance liquid chromatography of qinghaosu in animal plasmaAnalytical Chemistry, 1986